Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Gilead’s Trodelvy approved by FDA for metastatic breast cancer

HR+/HER2- is the most common type of breast cancer, accounting for 70% of new cases

- PMLiVE

World Health Organization releases new road map for breast cancer

Nearly 80% of breast and cervical cancer deaths occur in low- and middle-income countries

- PMLiVE

Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer

Endometrial cancer is the sixth most common cancer in women worldwide

- PMLiVE

Making new year resolutions that can also benefit others

Consider resolutions that could make 2023 a better year for many

- PMLiVE

ICR calls for improved biomarker cancer tests to help personalise treatment

Each cancer has a unique pattern of biomarkers that can affect how effective treatments are

- PMLiVE

AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer

Around 210,000 people worldwide are diagnosed with the disease each year

- PMLiVE

World Cancer Day: encouraging men to put their health first

A three-year campaign, running from 2022 to 2024, focuses on ‘Closing the Care Gap’

- PMLiVE

EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models

Endometrial cancer is the fourth most common cancer affecting women in the UK, with around 9,700 new cases every year

- PMLiVE

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines

Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients

- PMLiVE

Strategic behaviour

Strong strategising depends on your colleagues’ behaviour

- PMLiVE

Fishawack Health welcomes Mario Muredda as its new President of Marketing

Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.

Avalere Health

- PMLiVE

Roche’s Polivy recommended by NICE for lymphoma therapy

Around 5,500 people in England are diagnosed with the aggressive blood cancer each year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links